| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.09 |